Mahesh Hiremath

9 Jewel Pharmaceutical Companies in India with Global Presence India's pharmaceutical industry is making significant waves globally, with several companies leading the charge. Here are 9 notable pharmaceutical companies in India with a strong global presence I have been narrated about India's Navaratna Companies Like few ONGC BHEL NALCO etc Where not a Single Pharma Company features Though we Have Few Govt Companies But not like Public limited Govt Companies of India Like Hindustan Antibiotics Bengal Chemicals IDPLEtc However the following are 9 Jewels Pvt Pharma Companies. 1- Top Players - Sun Pharmaceutical Industries Ltd India's largest pharmaceutical company with operations in over 100 countries. 2 - Dr. Reddy's Laboratories A leading innovator with presence in over 40 countries. 3 - Cipla Ltd Known for affordable, high-quality pharmaceuticals in over 80 countries. 4 - Lupin Pharmaceuticals Ltd Global leader in generics and specialty medicines. 5 - Aurobindo Pharma Ltd Major players in global pharmaceuticals with presence in over 150 countries. 6 -Cadila Healthcare (Zydus Cadila) Innovation-driven with global presence. 7 - Torrent Pharmaceuticals Focus on research and development with global reach. 8 - Glenmark Pharmaceuticals Research-driven presence in over 80 countries. 9 - Alkem Laboratories Formulations in various therapeutic areas with exports to over 70 countries. #indianpharmamanufacturers# #globalindiahealthmission# #indianpharmaranddhouses# #indianpharmaexporters# #leadingindianpharmacompanies#

209

14 Comments

The USFDA isn’t a hurdle. It’s a growth strategy 📈 Every company dreads inspections. But here’s the truth: ▪️ The most resilient Indian pharma companies embrace the USFDA — and build to meet it. ▪️ A successful USFDA audit isn’t just a compliance win. It’s a passport to global trust, investor confidence, and long-term margins. Instead of fearing the regulator, let’s build for the world 🌍 That’s how Indian pharma scales.

79

9 Comments

India’s Cosmetic Regulation: A Giant Leap Toward Safety, Transparency & Global Alignment I’m excited to share my latest piece exploring the landmark amendments in India’s cosmetic regulatory landscape—paving the way for safer, more transparent, and internationally aligned personal care products. In this post, I delve into the key highlights of the new Cosmetic Rules Amendment 2025 (gazetted recently by the CDSCO), including: Embracing Digital Record‑Keeping: Manufacturers are now officially permitted to maintain electronic records for manufacturing and quality control—simplifying operations and aligning practices with global standards. Streamlined Export Labeling: Exporters can now adapt labels to meet importing country requirements, as long as a neutral code is present—boosting competitiveness while retaining regulatory clarity. Greater Regulatory Controls: Inspired by global benchmarks, these changes recalibrate India’s cosmetic industry toward robust safety and accountability. This regulatory overhaul signals a shift toward sophistication in compliance—benefiting consumers, businesses, and global trade alike. Read the full article to explore the details that make this reform a breakthrough moment for India’s beauty and personal care sector! https://lnkd.in/g55PdGjj

101

1 Comment

Memory of 1st September 2011 (Ganesh Chaturthi) . The Story of the Book That Changed the Destinies of Pharma Brand Managers Picture this: It's September 1st, 2011. The pharmaceutical industry is buzzing with excitement. Brand managers and aspiring marketing professionals across India are active, their eyes gleaming with anticipation. What's causing this stir? It is the long-awaited release of the ground-breaking book that would reshape the destinies of brand managers. "WHAT THE PHARMA CEO WANTS FROM THE BRAND MANAGER" hit the world of brand management, marking a pivotal moment in the industry. This wasn't just any book—it was the first of its kind, dedicated exclusively to pharma brand management. Written by a brand manager, for brand managers, it was born from the trenches of real-world experience. As word spread, young professionals and students flocked to get their hands on this treasure trove of knowledge. The book became a beacon, guiding hundreds into the intricate world of brand building in the pharmaceutical sector. Its pages held the secrets to becoming not just a good brand manager, but an exemplary one. But the story doesn't end there. The future-looking author, who is ever-committed to staying current with the ever-evolving changes, continued to develop and be current with the industry. As years passed, the book underwent multiple transformations, each edition reflecting the latest trends and strategies in pharma marketing. Fast forward to 1 September 2025 —14 years since its initial release. The book, now in its sixth edition, has been tweaked "WHAT THE 21ST CENTURY PHARMA CEO WANTS FROM THE BRAND MANAGER." This latest version doesn't just rehash old concepts; it dives headfirst into the future. A full chapter is dedicated to artificial intelligence, exploring how generative AI and prompt engineering are reshaping the role of brand managers. From its humble beginnings to becoming an industry staple, this book has mirrored the journey of pharmaceutical marketing itself—adapting, growing, and embracing the future. As you hold this book in your hands, remember: you're not just reading a marketing guide; you're holding a piece of pharmaceutical history. Available now on Amazon, Flipkart, and Pothi - your gateway to mastering the art and science of pharma brand management in the 21st century. Shailaja Dwivedi Pathak

26

1 Comment